View Older Stories View More Recent Stories

Apr 10, 2019 07:45AM Zealand Pharma grants new warrants under employee warrant program
Apr 8, 2019 02:00PM Zealand Pharma to attend Kempen Life Sciences Conference
Apr 5, 2019 06:10AM Zealand Pharma (ZEAL) Names Emmanuel Dulac CEO
Apr 5, 2019 06:00AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Apr 5, 2019 01:00AM Zealand Pharma announces Emmanuel Dulac as new CEO
Apr 5, 2019 01:00AM Zealand Pharma announces Emmanuel Dulac as new CEO
Apr 2, 2019 07:00AM Zealand Pharma to attend Needham Healthcare Conference
Mar 29, 2019 05:00PM Total number of shares and voting rights in Zealand Pharma at March 31, 2019
Mar 20, 2019 07:01AM Zealand Pharma increases its share capital as a consequence of a new issue of shares
Mar 15, 2019 05:35AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Mar 7, 2019 09:00AM Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
Mar 7, 2019 04:00AM Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
Mar 6, 2019 06:12AM Zealand Pharma (ZEAL) Reports First Patient Dosing in Phase 3 Trial with Dasiglucagon for Treatment of Congenital Hyperinsulinism
Mar 5, 2019 10:00PM Zealand Pharma doses first patient in Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism
Feb 28, 2019 09:01AM Zealand Pharma announces registration of executive management and an update of the Articles of Association
Feb 5, 2019 08:05AM Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study
Jan 4, 2019 01:00AM Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum
Jan 3, 2019 11:06PM Zealand Pharma completes equity investment in strategic partner Beta Bionics
Dec 28, 2018 03:00AM Total number of shares and voting rights in Zealand Pharma at December 31, 2018
Dec 14, 2018 03:22AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Dec 10, 2018 04:00AM Financial calendar for Zealand Pharma in 2019
Nov 26, 2018 10:03AM Zealand Pharma (ZEAL) CEO Britt Meelby Jensen to Resign
Nov 26, 2018 05:00AM Zealand Pharma announces change in Executive Management
Nov 15, 2018 09:01AM Zealand Pharma - Interim report for the first nine months of 2018
Nov 15, 2018 09:01AM Zealand Pharma - Interim report for the first nine months of 2018
Nov 12, 2018 07:01AM Zealand Pharma to attend Jefferies and Bryan, Garnier & Co Healthcare Conferences
Nov 8, 2018 04:54AM Zealand hosts conference call on November 15 at 4 pm CET (10 am EST) to present third quarter results for 2018
Oct 4, 2018 05:41AM Zealand Pharma (ZEAL) Reports First Patient Enrollment in Phase 3 trial with Glepaglutide for treatment of SBS
Oct 4, 2018 05:33AM Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome
Oct 4, 2018 05:33AM Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome
Oct 1, 2018 07:48AM Zealand Pharma expands leadership team and appoints Marino Garcia as Senior Vice President of Corporate & Business Development
Oct 1, 2018 07:48AM Zealand Pharma expands leadership team and appoints Marino Garcia as Senior Vice President of Corporate & Business Development
Sep 27, 2018 08:55AM Zealand Pharma (ZEAL) initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Sep 27, 2018 08:54AM Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Sep 27, 2018 08:54AM Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Sep 18, 2018 08:16AM Zealand Pharma (ZEAL) Says it Achieves Primary and key Secondary Endpoints in Phase 3 Trial with Dasiglucagon for Severe Hypoglycemia
Sep 18, 2018 08:14AM Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
Sep 18, 2018 08:14AM Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
Sep 14, 2018 03:46AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Sep 14, 2018 03:46AM Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Sep 7, 2018 08:18AM Zealand Pharma to attend J.P. Morgan Cazenove and Morgan Stanley Global Healthcare Conferences
Sep 7, 2018 05:52AM Zealand Pharma (ZEAL) Reports Sale of Royalty Streams & Milestones to Royalty Pharma for $205M
Sep 6, 2018 04:05PM Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma
Sep 6, 2018 04:05PM Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma
Aug 16, 2018 09:01AM Zealand Pharma - Interim report for the first half of 2018
Aug 13, 2018 06:58AM Zealand hosts conference call on August 16 at 4 pm CET/10 am EDT to present first half of 2018 results
Jul 31, 2018 01:49AM Zealand announces an 85% increase in Soliqua® 100/33/ Suliqua® royalty revenue from first to second quarter of 2018
Jul 11, 2018 10:58AM Zealand Pharma major shareholder announcement: Van Herk Investments
Jun 23, 2018 10:02AM Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA)
Jun 23, 2018 10:00AM Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions
View More Recent Stories View Older Stories